1. A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis. (21st January 2014) Authors: Lenglet, T.; Lacomblez, L.; Abitbol, J. L.; Ludolph, A.; Mora, J. S.; Robberecht, W.; Shaw, P. J.; Pruss, R. M.; Cuvier, V.; Meininger, V.; Meininger, Vincent; Lacomblez, Pr Lucette; Salachas, François; Bruneteau, Gaëlle; Pradat, Pierre‐François; Lenglet, Timothée; Lebouteux, Marie; Pibiri, Vanes... Journal: European journal of neurology Issue: Volume 21:Number 3(2014:Mar.) Page Start: 529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study. Issue 5 (May 2022) Authors: De Cock, Valérie Cochen; Dodet, Pauline; Leu-Semenescu, Smaranda; Aerts, Cécile; Castelnovo, Giovanni; Abril, Beatriz; Drapier, Sophie; Olivet, Hélène; Corbillé, Anne-Gaëlle; Leclair-Visonneau, Laurène; Sallansonnet-Froment, Magali; Lebouteux, Marie; Anheim, Mathieu; Ruppert, Elisabeth; Vitello, ... Journal: Lancet neurology Issue: Volume 21:Issue 5(2022) Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Subcutaneous apomorphine in the treatment of progressive supranuclear palsy and corticobasal syndrome: A preliminary study of 7 cases. (February 2022) Authors: Hubsch, Cécile; Ivan Mari, Marc Ziegler; Léguillier, Teddy; Lebouteux, Marie; Brandel, Jean-Philippe Journal: Parkinsonism & related disorders Issue: Volume 95(2022) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗